SCYX · Company research
SCYNEXIS, Inc. (SCYX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
17records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Scynexis Stock Price Forecast. Should You Buy SCYX? - StockInvest.us | Scynexis Stock Price Forecast. Should You Buy SCYX? StockInvest.us | View source ↗ | StockInvest.us | Oct 9, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS (NasdaqCM:SCYX) Stock Forecast & Analyst Predictions - Simply Wall Street | SCYNEXIS (NasdaqCM:SCYX) Stock Forecast & Analyst Predictions Simply Wall Street | View source ↗ | Simply Wall Street | Oct 6, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS Inc. (SCYX) Edges Up 0.87% to $4.66 as Shares Hold Above Key Support - Gamma Flip Level - https://www.siam.in/ | SCYNEXIS Inc. (SCYX) Edges Up 0.87% to $4.66 as Shares Hold Above Key Support - Gamma Flip Level https://www.siam.in/ | View source ↗ | https://www.siam.in/ | Sep 29, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS Inc. (SCYX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com | SCYNEXIS Inc. (SCYX) Stock Price | Live Quotes & Charts | NASDAQ timothysykes.com | View source ↗ | timothysykes.com | Sep 28, 2026 | neutral | 0 | 0.6 |
| A U.S. health agency could provide up to about $214 million to develop an antifungal treatment if all options are exercised. - Stock Titan | A U.S. health agency could provide up to about $214 million to develop an antifungal treatment if all options are exercised. Stock Titan | View source ↗ | Stock Titan | Sep 28, 2026 | neutral | 0 | 0.6 |
| SCYX Stock Draws Trader Focus As New CFO And ADPKD Pivot Take Shape - Timothy Sykes | SCYX Stock Draws Trader Focus As New CFO And ADPKD Pivot Take Shape Timothy Sykes | View source ↗ | Timothy Sykes | Sep 28, 2026 | neutral | 0 | 0.6 |
| Scynexis (NASDAQ: SCYX) adds kidney drug specialist to its board - Stock Titan | Scynexis (NASDAQ: SCYX) adds kidney drug specialist to its board Stock Titan | View source ↗ | Stock Titan | Sep 22, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS appoints new CFO amid leadership transition - The Globe and Mail | SCYNEXIS appoints new CFO amid leadership transition The Globe and Mail | View source ↗ | The Globe and Mail | Sep 11, 2026 | neutral | 0 | 0.6 |
| The Technical Signals Behind (SCYX) That Institutions Follow - Stock Traders Daily | The Technical Signals Behind (SCYX) That Institutions Follow Stock Traders Daily | View source ↗ | Stock Traders Daily | Sep 7, 2026 | neutral | 0 | 0.6 |
| (SCYX) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily | (SCYX) Movement Within Algorithmic Entry Frameworks Stock Traders Daily | View source ↗ | Stock Traders Daily | Aug 28, 2026 | neutral | 0 | 0.6 |
| Scynexis stock price target reiterated at $44.64 by Brookline - Investing.com | Scynexis stock price target reiterated at $44.64 by Brookline Investing.com | View source ↗ | Investing.com | Jul 31, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS (NASDAQ:SCYX) Is In A Strong Position To Grow Its Business - Simply Wall Street | SCYNEXIS (NASDAQ:SCYX) Is In A Strong Position To Grow Its Business Simply Wall Street | View source ↗ | Simply Wall Street | Jul 3, 2026 | neutral | 0 | 0.6 |
| SCYX Forecast — Price Target — Prediction for 2027 - TradingView | SCYX Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 25, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS (SCYX) Announces 1-for-8 Reverse Stock Split to Meet Na - GuruFocus | SCYNEXIS (SCYX) Announces 1-for-8 Reverse Stock Split to Meet Na GuruFocus | View source ↗ | GuruFocus | May 22, 2026 | neutral | 0 | 0.6 |
| SCYNEXIS INC (NASDAQ:SCYX) Combines Minervini Trend Template with High-Growth Momentum Fundamentals - ChartMill | SCYNEXIS INC (NASDAQ:SCYX) Combines Minervini Trend Template with High-Growth Momentum Fundamentals ChartMill | View source ↗ | ChartMill | Apr 13, 2026 | neutral | 0 | 0.6 |
| Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement – SCYX Stock Climbs 2% Pre-Market - Stocktwits | Scynexis In Spotlight After Poxel Deal, $40 Million Private Placement – SCYX Stock Climbs 2% Pre-Market Stocktwits | View source ↗ | Stocktwits | Mar 31, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jan 14, 2024 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.